Songgang Yi

Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth

Ping Zhou, Wenbin Song, Li Xu, 2014, Oncotarget.

A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidases

Q. Dou, Jinbao Liu, P. Zhou, 2014, Scientific Reports.

A microRNA-mediated decrease in eukaryotic initiation factor 2α promotes cell survival during PS-341 treatment

D. Zang, Jinbao Liu, Xiaofen Li, 2016, Scientific Reports.